Forza Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Forza Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$438K	Hold	881	–	–	0.13%	141
2026 Q1	$393K	Hold	881	–	–	0.14%	145
2025 Q4	$399K	Hold	881	–	–	0.14%	142
2025 Q3	$345K	Hold	881	–	–	0.13%	147
2025 Q2	$392K	Hold	881	–	–	0.16%	139
2025 Q1	$427K	Hold	881	–	–	0.19%	123
2024 Q4	$355K	Buy	881 +49	+6%	+$22.7K	0.16%	139
2024 Q3	$387K	Sell	832 -1	-0.1%	-$480	0.18%	137
2024 Q2	$390K	Hold	833	–	–	0.2%	130
2024 Q1	$348K	Hold	833	–	–	0.18%	135
2023 Q4	$339K	Hold	833	–	–	0.19%	132
2023 Q3	$290K	Hold	833	–	–	0.15%	151
2023 Q2	$293K	Hold	833	–	–	0.15%	152
2023 Q1	$262K	Hold	833	–	–	0.14%	157
2022 Q4	$241K	Buy	+833	New	+$254K	0.16%	129

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Forza Wealth Management's VRTX Position: Q2 2026 in Review

Forza Wealth Management held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 881 shares worth $438K. The position accounts for 0.13% of the portfolio, ranked #141.

Forza Wealth Management first reported a position in VRTX in Q4 2022 and has held it in 15 quarters since. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Forza Wealth Management held 881 shares of Vertex Pharmaceuticals worth $438K as of Q2 2026.
Forza Wealth Management left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.13% of Forza Wealth Management's portfolio in Q2 2026, its #141 holding.
Forza Wealth Management first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Forza Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.